Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Report Overview
The Brazil clinical trials market was valued at USD 1.58 Billion in 2025, driven by rising biotechnology investments and strengthened regulatory support with enhanced infrastructure initiatives in the region. The market is anticipated to grow at a CAGR of 4.90% during the forecast period of 2026-2035, with the values likely to reach USD 2.55 Billion by 2035. The increasing prevalence of conditions such as diabetes, cancer, and cardiovascular diseases is driving demand for new treatments and, in turn, clinical research.
Key Market Trends and Insights
- Brazil offers a genetically diverse and treatment-naïve patient pool, enabling faster recruitment and broader applicability of clinical trial results. There the market is expected to witness growth in the region.
- Brazil's clinical trials market is witnessing an increased adoption of decentralized trial models and digital health tools, driven by regulatory reforms and a rising focus on patient-centric studies across diverse therapeutic areas.
- The increasing government initiatives and regulatory reforms are enhancing the efficiency of clinical trials in Brazil, fostering growth by attracting global players and ensuring compliance with international standards.
Market Size and Forecast
- Market Size in 2025: USD 1.58 Billion
- Projected Market Size in 2035: USD 2.55 Billion
- CAGR from 2026 to 2035: 4.90%
Compound Annual Growth Rate
4.9%
Value in USD Billion
2026-2035
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Brazil Clinical Trials Market Overview
According to Regulatory Focus factsheet, Brazil registered around 10,000 clinical studies by April 2024. Clinical trials are essential for advancing medical knowledge and ensuring the approval of new therapies. The market is growing rapidly due to favorable government policies, increasing investments, and a large, diverse patient population. Brazil's expanding healthcare infrastructure, combined with a rising demand for clinical research activities, makes the country an attractive destination for conducting clinical trials.
Brazil Clinical Trials Market Growth Drivers
Rising Cancer Incidence to Accelerate the Market Growth
The increasing incidence of cancer is a major growth driver for the clinical trials market in Brazil. According to data published in July 2024, new cancer cases in Brazil rose significantly from approximately 489,000 in 2010 to about 704,000 in 2023. This sharp increase, especially in prostate cancer cases, is intensifying the need for innovative therapies, thereby supporting continued market growth in the forecast period.
Brazil Clinical Trials Market Trends
Novartis highlighted Brazil's growing role in global clinical research in August 2026, noting the country's strengthened regulatory framework and its potential for conducting clinical studies in strategic therapeutic areas. The company is increasing its attention to Brazil as the new clinical-research framework improves the country's attractiveness for multinational research programmes. Greater participation by global pharmaceutical companies can increase demand for clinical sites, investigators, patient recruitment, monitoring and other outsourced trial-management services, supporting expansion of the Brazil clinical trials market.
Brazil secured 51 new clinical trials during the first half of 2026, according to data reported in July 2026, helping the country rise from 18th to 12th place among the most attractive countries for international clinical research. The improvement reflects the early impact of Brazil's updated clinical-research framework and growing interest from international sponsors. Rising trial volumes can stimulate demand for research sites, contract research organizations, patient recruitment, clinical data management and regulatory services, strengthening Brazil's position in the global clinical research ecosystem, thus boosting Brazil clinical trials market growth.
Brazil's Ministry of Health launched the National Clinical Research Programme in April 2026 and announced R$120 million to support innovation through the Unified Health System (SUS). The programme aims to position Brazil as a strategic hub within the global health-technology R&D network while expanding national capacity to conduct clinical trials across development phases. Government investment in research infrastructure, innovation and clinical-trial capabilities can strengthen domestic research capacity and create additional opportunities for sponsors, investigators and clinical research organizations.
Brazil published Decree No. 12,651/2025 on 8 October 2025, regulating Law No. 14,874/2024 and establishing the framework for the National System of Ethics in Clinical Trials involving human subjects. The decree defines the roles of the National Research Ethics Board and Institutional Review Boards while introducing transitional rules for accreditation and certification. Greater clarity around ethical oversight and approval procedures can improve regulatory predictability for pharmaceutical companies and research organizations, supporting increased clinical-trial activity in Brazil.
Regulatory Modernization Accelerating Clinical Research Activity
Brazil's clinical research environment is undergoing regulatory modernization following the implementation of RDC 945/2024 and the broader framework established by Law No. 14,874/2024. The updated framework is designed to improve regulatory processes, strengthen alignment with international standards, and provide greater predictability for sponsors. The effect is already visible in activity levels, with Anvisa reporting an 11% increase in requests for clinical research in Brazilian centers between 2024 and 2025. Greater regulatory clarity can encourage multinational pharmaceutical and biotechnology companies to include Brazil in multicounty development programmes.
Increasing Participation of Multinational Pharmaceutical Companies
Investment from global pharmaceutical companies in Brazil remains high due to the country’s vast patient base and its well-developed research facilities and pharmaceutical sector. The recent trends in the sector reveal that multinational companies have continued investing in Brazil, especially in conducting clinical trials through companies like Alexion/AstraZeneca. Global companies consider research facilities in Brazil an important asset in collecting evidence in a diverse patient base, which boosts demand for CRO services, hence driving the growth of the Brazil clinical trials market.
Growing Focus on Rare-Disease and Advanced Therapies
Clinical research in Brazil is increasingly extending into rare diseases, gene therapies and other advanced therapeutic modalities. The country has resumed targeted investments in gene-therapy development following Anvisa's approval of early clinical trials involving gene-therapy products. Rare-disease programmes can generate additional demand for specialized investigators, patient-identification systems, genomic testing, central laboratories and long-term patient monitoring, thereby creating opportunities for specialized clinical research organizations and trial sites.
Greater Adoption of Fast-Track and Reliance-Based Regulatory Pathways
Brazil has begun implementing more efficient systems for reviewing clinical trials. For instance, the Brazilian Clinical Trials Registry (ReBEC) has established a fast track for clinical trials and observational studies for Indigenous and traditional peoples and tropical neglected diseases, with the time needed to process applications possibly reduced to less than 48 hours. Additionally, the new structure of Anvisa includes reliance principles, which allow the agency to rely on results from regulatory bodies from other countries. These approaches can shorten administrative timelines and improve Brazil's attractiveness for sponsors seeking faster trial initiation.
Expansion of Clinical Research Infrastructure and Outsourcing
The increasing complexity of pharmaceutical development is encouraging sponsors to rely more heavily on specialized CROs, academic institutions, and dedicated research centers. Brazil's extensive healthcare network and geographically distributed patient population provide opportunities for multicenter studies, while international sponsors can outsource site management, patient recruitment, monitoring, regulatory submissions and data-management activities. As trial designs become more complex, demand is likely to increase for specialised clinical research capabilities rather than conventional single-site research services.
Brazil Clinical Trials Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Phase
- Phase I
- Phase II
- Phase III
- Phase IV
Market Breakup by Service Type
- Laboratory Services
- Bioanalytical Testing Services
- Cell-Based Assay
- Virology Testing
- Serology, Immunogenicity, & Neutralizing Antibodies
- PK/PD Testing
- Method Development, Optimization & Validation
- Biomarker Testing
- Other Bioanalytical Testing Services
- Decentralized Clinical Trial Services
- Patient Recruitment
- Site Identification
- Analytical Testing Services
- Clinical Trial Supply & Logistic Services
- Protocol Designing
- Clinical Trial Data Management Services
- Medical Device Testing Services
- Other Service
Market Breakup by Therapeutic Areas
- Oncology
- Infectious Diseases
- Neurology
- Metabolic Disorders
- Immunology
- Cardiology
- Genetic Diseases
- Women's Health
- Other Therapeutic Areas
Market Breakup by Type of Pharmaceutical Product
- Small Molecules
- Monoclonal Antibodies
- Vaccine
- Cell & Gene Therapy
- Other Applications
Market Breakup by Study Design
- Interventional
- Observational
Market Breakup by Delivery Model
- Full-Service Outsourcing (FSO) Model
- Functional Service Provider (FSP) Model
- Hybrid Model
Market Breakup by End User
- Pharmaceutical & Biopharmaceutical Companies
- Medical Devices Companies
- Academic Institutes
- Other
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Brazil Clinical Trials Market Share
Patient Recruitment Services Type Segmentation to Lead the Brazil Clinical Trials Market
The market is divided into a variety of service types, including laboratory services, bioanalytical testing services, patient recruitment, decentralized clinical trials, clinical trial supply and logistics, and more. Among these, patient recruitment services are expected to dominate. The effectiveness of a clinical trial often depends on the speed and accuracy of patient recruitment, which is essential for timely trial completion and accurate results. As the demand for clinical trials across therapeutic areas continues to grow, efficient patient recruitment will be a significant driver of market success in Brazil.
Oncology to Witness Substantial Growth in the Market Segmentation by Therapeutic Areas
There is an emphasis clinical trials on several therapeutic areas, including oncology, infectious diseases, neurology, cardiology, and metabolic disorders, among others. According to projections by the Brazilian National Cancer Institute (INCA), Brazil is expected to record over 704,000 new cancer cases each year between 2023 and 2025, excluding non-melanoma skin cancers. As a result, oncology is projected to be the leading therapeutic area due to the increasing prevalence of cancer in Brazil and worldwide. With rising investments in cancer research and the growing demand for new treatment options, clinical trials in oncology are expected to dominate. These trials are pivotal for the development of cutting-edge cancer therapies, making oncology a focal point of clinical research in the Brazilian market.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Leading Players in the Brazil Clinical Trials Market
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Cohortias
Cohortias, established as a full-service Contract Research Organization (CRO) that specializes in clinical trials across Latin America. Established to meet the growing demand for clinical research, Cohortias offers services like early-phase studies, rescue studies, and phase II and III trials, along with medical device trials. They are renowned for their expansive network, with over 250 sites and 10,500 conducted studies. Cohortias focuses on therapeutic areas including oncology, cardiology, and infectious diseases, playing a pivotal role in advancing clinical research in Brazil and the wider Latin American region.
Parexel Brazil
Parexel operates across multiple regions, including Brazil, where it supports clinical trial services. The company offers end-to-end clinical development services. Parexel specializes in phases I-IV trials, helping accelerate drug development globally. Their involvement in Brazil’s clinical trials market is vital due to its vast patient population and the company’s deep expertise in clinical, regulatory, and market access solutions, supporting a wide range of trials, including rare diseases and vaccines.
PPD (Thermo Fisher Scientific Inc.)
PPD, a Thermo Fisher Scientific company, focuses on early-phase clinical trials, particularly Phase I and Ib studies, assessing the clinical relevance and commercial viability of compounds. Their services include patient recruitment, investigator engagement, and trial design, ensuring the success of subsequent trials. PPD’s expertise in early clinical development leverages extensive global resources, making them a significant player in the clinical trials market, supporting both patient safety and regulatory submission processes.
ICON plc
ICON plc is a prominent global Contract Research Organization (CRO). It was established in 1990 and is headquartered in Dublin, Ireland. With a significant presence in Latin America, including Brazil, ICON conducts clinical trials across various therapeutic areas, including cardiovascular, cancer, and infectious diseases. ICON’s expertise in local regulations, patient enrollment, and cultural understanding allows it to effectively manage complex clinical trials. The company’s commitment to high-quality research and patient retention has solidified its leadership in Brazil's growing clinical trials market, making it a trusted partner for global and regional study delivery.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Fractals Clinical Research, IQVIA Inc., Medpace, ACTIVA-CRO, and Centre International de Développement Pharmaceutique Ltee (CIDP).
Key Questions Answered in the Brazil Clinical Trials Market Report
- What was the Brazil clinical trials market value in 2025?
- What is the Brazil clinical trials market forecast outlook for 2026-2035?
- What are the major factors aiding the Brazil clinical trials market demand?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What is the major Brazil clinical trials market trends?
- Which phase is expected to dominate the market segment?
- Which service type is projected to lead the market segment?
- Which therapeutic area is anticipated to drive the market segment?
- Which application is likely to dominate the market segment?
- Who are the key players involved in the Brazil clinical trials market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Pricing Plans
Upto 15% Off
USD
-
$1999 $1799
-
$3099 $2789
-
$4599 $3909
-
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Phase |
|
| Breakup by Service Type |
|
| Breakup by Therapeutic Areas |
|
| Breakup by Pharmaceutical Product |
|
| Breakup by Study Design |
|
| Breakup by Delivery Model |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
